Deltex Medical Group plc
Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler and pulse contour analysis and monitoring platform. It offers dopplink, a patient interface cable; and pressurewave, an arterial blood pressure signal under the TrueVue brand. The company also provides oesophageal doppler monitoring systems. Deltex Medical Group plc was incorporated in 2… Read more
Market Cap & Net Worth: Deltex Medical Group plc (DTXMF)
Deltex Medical Group plc (PINK:DTXMF) has a market capitalization of $180.50 Million ($180.50 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #19357 globally and #7126 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Deltex Medical Group plc's stock price $0.10 by its total outstanding shares 1896025700 (1.90 Billion).
Deltex Medical Group plc Market Cap History: 2015 to 2025
Deltex Medical Group plc's market capitalization history from 2015 to 2025. Data shows growth from $172.54 Million to $180.50 Million (0.48% CAGR).
Deltex Medical Group plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Deltex Medical Group plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.77x
Deltex Medical Group plc's market cap is 2.77 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $172.54 Million | $6.41 Million | -$3.46 Million | 26.94x | N/A |
| 2016 | $66.36 Million | $6.33 Million | -$2.38 Million | 10.48x | N/A |
| 2017 | $66.36 Million | $5.87 Million | -$2.00 Million | 11.31x | N/A |
| 2018 | $18.96 Million | $4.96 Million | -$1.26 Million | 3.83x | N/A |
| 2019 | $56.88 Million | $4.26 Million | -$159.00K | 13.36x | N/A |
| 2020 | $56.88 Million | $2.40 Million | -$785.00K | 23.72x | N/A |
| 2021 | $56.88 Million | $2.26 Million | -$966.00K | 25.18x | N/A |
| 2022 | $15.17 Million | $2.48 Million | -$1.15 Million | 6.11x | N/A |
| 2023 | $2.46 Million | $1.78 Million | -$1.28 Million | 1.39x | N/A |
| 2024 | $5.69 Million | $2.06 Million | -$1.80 Million | 2.77x | N/A |
Competitor Companies of DTXMF by Market Capitalization
Companies near Deltex Medical Group plc in the global market cap rankings as of March 18, 2026.
Key companies related to Deltex Medical Group plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Deltex Medical Group plc Historical Marketcap From 2015 to 2025
Between 2015 and today, Deltex Medical Group plc's market cap moved from $172.54 Million to $ 180.50 Million, with a yearly change of 0.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $180.50 Million | +3073.33% |
| 2024 | $5.69 Million | +130.77% |
| 2023 | $2.46 Million | -83.75% |
| 2022 | $15.17 Million | -73.33% |
| 2021 | $56.88 Million | 0.00% |
| 2020 | $56.88 Million | 0.00% |
| 2019 | $56.88 Million | +200.00% |
| 2018 | $18.96 Million | -71.43% |
| 2017 | $66.36 Million | 0.00% |
| 2016 | $66.36 Million | -61.54% |
| 2015 | $172.54 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Deltex Medical Group plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $180.50 Million USD |
| MoneyControl | $180.50 Million USD |
| MarketWatch | $180.50 Million USD |
| marketcap.company | $180.50 Million USD |
| Reuters | $180.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.